文献速递产科母胎医学

染色体微阵列产前诊断后先天性心脏病胎儿的妊娠结局

Pregnancy outcomes of fetuses with congenital heart disease after a prenatal diagnosis with chromosome microarray.
PubMed 文献 · Prenat Diagn · 2021-12-16

研究纳入2014年9月至2019年12月间1035例怀有先天性心脏病(CHD)胎儿的孕妇,行羊膜腔穿刺及染色体微阵列(CMA)检测,随访妊娠结局6个月至5年。CMA总体CHD检出率为10.1%(105/1035),其中50例为非整倍体,55例为致病或可能致病拷贝数变异。染色体异常胎儿终止妊娠率显著高于无染色体异常胎儿(93.1% vs. 15.5%,p < 0.001),但两组死亡率、早产率和低出生体重率相似;自愈型CHD占52.6%(401例)。

要点

  • CMA总体CHD检出率为10.1%(105/1035),包括50例非整倍体和55例致病/可能致病拷贝数变异。
  • 染色体异常胎儿终止妊娠率为93.1%,显著高于无染色体异常胎儿的15.5%(p < 0.001)。
  • 两组死亡率、早产率和低出生体重率相似;自愈型CHD占52.6%(401例)。

核心结论

  • CMA结果是不影响父母选择是否继续妊娠的重要因素。
  • 产前诊断的CHD自愈率高。
  • 经产前CMA检测的CHD胎儿死亡率和发病率相对较低。

研究设计与样本

  • 研究于2014年9月至2019年12月对1035例怀有CHD胎儿的孕妇行羊膜腔穿刺,采用CMA评估染色体异常,并随访妊娠结局6个月至5年。

主要发现

  • CMA总体CHD检出率为10.1%(105/1035),其中50例为非整倍体,55例为致病或可能致病拷贝数变异。
  • 1003例随访胎儿中,流产4例、终止妊娠236例、活产763例、出生后死亡18例。
  • 自愈型CHD见于401例(52.6%)。
  • 染色体异常胎儿终止妊娠率为93.1%,显著高于无染色体异常胎儿的15.5%(p < 0.001)。
  • 两组死亡率、早产率和低出生体重率相似。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the pregnancy outcomes of fetuses with congenital heart disease (CHD) after chromosome microarray (CMA)-based prenatal diagnosis. METHOD: Amniocentesis was performed in 1035 pregnant women carrying fetuses with CHD between September 2014 and December 2019. Chromosomal aberrations in fetuses with CHD were evaluated using CMA. The pregnancy outcomes were followed up from 6 months to 5 years. RESULTS: The overall CHD detection rate by CMA was 10.1% (105/1035; 50 fetuses: aneuploidy, 55 fetuses: pathogenic or likely pathogenic copy number variations). Among 1003 fetuses who were followed up, 4, 236, 763, and 18 cases were of miscarriages, pregnancy termination, live births, and postnatal deaths, respectively. Self-healed CHD was observed in 401 (52.6%) fetuses. The pregnancy termination rate of fetuses with chromosomal anomalies was significantly higher than that of fetuses without chromosomal anomalies (93.1% vs. 15.5%, p < 0.001). However, other pregnancy outcomes, including mortality, preterm labor, and low-weight birth rate, were similar between the two groups. CONCLUSION: The outcome of CMA is an important factor influencing parents' choice of whether to continue the pregnancy. Self-healing rate of prenatal diagnosed CHD is high. The mortality and morbidity of fetuses with CHD following prenatal CMA testing are relatively low.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Zhang Z, Hu T, Wang J, et al. Pregnancy outcomes of fetuses with congenital heart disease after a prenatal diagnosis with chromosome microarray. Prenat Diagn. 2021. PMID: 34918366. doi:10.1002/pd.6078

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。